Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:3509-3534
doi: 10.1161/CIRCULATIONAHA.104.478362
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wharton, T. P.
Right arrow Articles by Grines, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wharton, T. P., Jr
Right arrow Articles by Grines, C. L.
Related Collections
Right arrow Catheter-based coronary interventions: stents
Right arrow Acute myocardial infarction

(Circulation. 2005;112:3509-3534.)
© 2005 American Heart Association, Inc.


Controversies in Cardiovascular Medicine

Should patients with acute myocardial infarction be transferred to a tertiary center for primary angioplasty or receive it at qualified hospitals in the community?

The Case for Community Hospital Angioplasty

Thomas P. Wharton, Jr, MD


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Primary percutaneous coronary intervention (PCI) has gained widespread acceptance as the preferred approach for treating ST-segment elevation acute myocardial infarction (STEMI) when it can be performed rapidly at qualified centers. Primary PCI is superior to fibrinolytic therapy in fibrinolytic-eligible patients with STEMI; it reduces the rates of death, reinfarction, cerebral bleeding, reocclusion of the infarct artery, and recurrent ischemia compared with fibrinolytic therapy.1,2 It is much more effective than fibrinolytic therapy in restoring brisk coronary flow (>90% of patients). In addition, primary PCI is potentially applicable to a much broader spectrum of patients with STEMI than is fibrinolytic therapy. It reduces mortality 2-fold or more in the large group of patients inappropriate for fibrinolytic therapy.3,4 It is particularly beneficial in women and the elderly.5,6 A recent report of Medicare patients demonstrated that fibrinolytic therapy conferred a survival disadvantage in patients >75 years old, especially in women, compared with no reperfusion therapy.6 This population represents almost one third of patients with acute myocardial infarction (AMI).7 The editorial that accompanied this study noted that "a recent observational study...has shown a marked reduction in 30-day mortality for primary PCI relative to fibrinolytic therapy in the elderly. However, primary PCI is not available at the hospitals where most elderly patients present with AMI."7


*    The Need to Improve Access to Primary PCI for Patients With AMI
 
Unfortunately, only a small minority of patients with STEMI are treated with primary PCI in the United States (Figure 1).8,9 The National Registry of Myocardial Infarction (NRMI) reports that the utilization of primary PCI has increased only slowly from . . . [Full Text of this Article]

Ellen C. Keeley, MD; Cindy L. Grines, MD

Thomas P. Wharton, Jr, MD

Ellen C. Keeley, MD; Cindy L. Grines, MD

Correspondence to Thomas P. Wharton, Jr, MD, The Perry Medical Services Building, Suite 101, 3 Alumni Drive, Exeter, NH 03833 (e-mail tom.wharton@comcast.net); or Ellen C. Keeley, MD, UT Southwestern Medical Center, Division of Cardiology, 5323 Harry Hines Blvd, Dallas, TX 75390-8837 (e-mail Ellen.Keeley@UTSouthwestern.edu).




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. A. Kutcher, L. W. Klein, F.-S. Ou, T. P. Wharton Jr, G. J. Dehmer, M. Singh, H. V. Anderson, J. S. Rumsfeld, W. S. Weintraub, R. E. Shaw, et al.
Percutaneous Coronary Interventions in Facilities Without Cardiac Surgery On Site: A Report From the National Cardiovascular Data Registry (NCDR).
J. Am. Coll. Cardiol., June 30, 2009; 54(1): 16 - 24.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V.S. Srinivas, S. M. Hailpern, E. Koss, E. S. Monrad, and M. H. Alderman
Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty.
J. Am. Coll. Cardiol., February 17, 2009; 53(7): 574 - 579.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
B. K. Nallamothu, E. H. Bradley, and H. M. Krumholz
Time to Treatment in Primary Percutaneous Coronary Intervention
N. Engl. J. Med., October 18, 2007; 357(16): 1631 - 1638.
[Full Text] [PDF]


Home page
NEJMHome page
E. C. Keeley and L. D. Hillis
Primary PCI for Myocardial Infarction with ST-Segment Elevation
N. Engl. J. Med., January 4, 2007; 356(1): 47 - 54.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. A. Bittl
Reply
J. Am. Coll. Cardiol., July 18, 2006; 48(2): 416 - 416.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. H. Ting, G. Raveendran, R. J. Lennon, K. H. Long, M. Singh, D. L. Wood, B. J. Gersh, C. S. Rihal, and D. R. Holmes Jr
A Total of 1,007 Percutaneous Coronary Interventions Without Onsite Cardiac Surgery: Acute and Long-Term Outcomes
J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1713 - 1721.
[Abstract] [Full Text] [PDF]